Long-term safety considerations The honest answer about long-term cagrilintide safety is that we do not fully know yet
By increasing glucose uptake in muscle cells, IGF-1 helps lower blood glucose levels, thereby reducing the need for insulin secretion (Clemmons, 2004)
Prader-Willi Syndrome (PWS), a severe neurogenetic syndrome with uncontrollable hyperphagia and high threshold for pain, is an excellent example of this issue
Alcohol may interact unpredictably for some individuals taking GLP-1 medications, which is why mindful alternatives can be a helpful option
The process of metformin exerting its extensive effects cannot be separated from the regulation of gut microbiota
Purpose-built for physicians Interrupting or stopping GLP-1s may reverse cardiovascular benefits Key takeaways: GLP-1s have cardiovascular benefits that accumulate with continuous use